Data-driven predictive modeling for cell line selection in biopharmaceutical production
AssigneeAmgen Inc.
InventorsKim H. Le, Yucen Xie, Jennitte LeAnn Stevens, Aaron Baskerville-Bridges
Life of this patent
Estimating the term…
Loading patent…
AssigneeAmgen Inc.
InventorsKim H. Le, Yucen Xie, Jennitte LeAnn Stevens, Aaron Baskerville-Bridges
Estimating the term…
A method for facilitating selection of cell lines to advance to a next stage of cell line screening includes receiving first attribute values for the candidate cell lines measured using an opto-electronic cell line generation and analysis system, and acquiring second attribute values that include one or more attribute values measured at a cell pool screening stage of the candidate cell lines. The method also includes determining a ranking of the candidate cell lines according to a product quality attribute associated with hypothetical small-scale screening cultures. Determining the ranking includes predicting, for each of the candidate cell lines, a value of the product quality attribute by analyzing the first and second plurality of attribute values using a machine learning based regression estimator, and comparing the predicted values. The method also includes causing an indication of the ranking to be presented to a user via a user interface.
A method for facilitating selection of a cell line, from among a plurality of candidate cell lines that produce recombinant proteins, the method comprising:
A method for facilitating selection of a master cell line from among candidate cell lines that produce recombinant proteins, the method comprising:
Dependencies are inferred from the claim text.